Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

  1. Rodrigues, J.S.
  2. Chenlo, M.
  3. Bravo, S.B.
  4. Perez-Romero, S.
  5. Suarez-Fariña, M.
  6. Sobrino, T.
  7. Sanz-Pamplona, R.
  8. González-Prieto, R.
  9. Blanco Freire, M.N.
  10. Nogueiras, R.
  11. López, M.
  12. Fugazzola, L.
  13. Cameselle-Teijeiro, J.M.
  14. Alvarez, C.V.
Revista:
Nature Communications

ISSN: 2041-1723

Ano de publicación: 2024

Volume: 15

Número: 1

Tipo: Errata

DOI: 10.1038/S41467-024-51057-7 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus